The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 685K Compounds and 4.6K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

9 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis and structure-activity relationships of novel substituted 8-amino, 8-thio, and 1,8-pyrazole congeners of antitubercular rifamycin S and rifampin.EBI
University of Michigan
Myxopyronin B analogs as inhibitors of RNA polymerase, synthesis and biological evaluation.EBI
Anadys Pharmaceuticals
Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency.EBI
Boehringer Ingelheim (Canada)
Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivatives.EBI
Boehringer Ingelheim (Canada)
X-ray crystal structures of the Escherichia coli RNA polymerase in complex with benzoxazinorifamycins.EBI
The Pennsylvania State University
Substituted 1,2-oxaborolan-2-ols as PDE4 inhibitorsBDB
Pfizer
Azetidine derivatives, pharmaceutical compositions and uses thereofBDB
Boehringer Ingelheim International
Factor Xa inhibitors: S1 binding interactions of a series of N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}sulfonamides.BDB
Gsk
p38 MAP kinase inhibitors. Part 3: SAR on 3,4-dihydropyrimido[4,5-d]pyrimidin-2-ones and 3,4-dihydropyrido[4,3-d]pyrimidin-2-ones.BDB
Merck Research Laboratories